MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1038/s41401-020-0442-2
Published Online: 2020-06-15
Published Print: 2021-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Shang, Jia-lin
Ning, Shao-bo
Chen, Ying-yi
Chen, Tian-xiang
Zhang, Jian
Text and Data Mining valid from 2020-06-15
Version of Record valid from 2020-06-15
Article History
Received: 22 March 2020
Accepted: 12 May 2020
First Online: 15 June 2020
Competing interests
: The authors declare no competing interests.